Skip to main navigation
Skip to search
Skip to main content
Sefako Makgatho Health Sciences University Home
Home
Profiles
Departments
Research output
Activities
Search by expertise, name or affiliation
Neuropathic pain: Targeting the melatonin MT<inf>2</inf> receptor
Natasha Smith
, Halima Ismail
, Natalie Schellack
Sefako Makgatho Health Sciences University
School of Science and Technology
Research output
:
Contribution to journal
›
Literature review
›
peer-review
2
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Neuropathic pain: Targeting the melatonin MT<inf>2</inf> receptor'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Neuropathic Pain
100%
Melatonin
100%
MT2 Receptor
100%
South African
12%
South Africa
12%
Chronic Pain
12%
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
12%
Neurohormone
12%
Opioids
12%
Correct Diagnosis
12%
Circadian Rhythm
12%
Inflammation
12%
Therapeutic Treatment
12%
Opioid Therapy
12%
Pain Affect
12%
Treatment Options
12%
First-line Therapy
12%
Person Ability
12%
Early Phase Clinical Trials
12%
Last Line
12%
Pharmacology, Toxicology and Pharmaceutical Science
Neuropathic Pain
100%
Melatonin 2 Receptor
100%
Opiate
25%
Melatonin
25%
Clinical Trial
12%
Inflammation
12%
Neurohormone
12%
Chronic Pain
12%
Medicine and Dentistry
Melatonin 2 Receptor
100%
Neuropathic Pain
100%
Melatonin
25%
Opiate
25%
Chronic Pain
12%
Neurohormone
12%
Clinical Trial
12%
Circadian Rhythm
12%